Whereas therapeutic studies have implicated C3 opsonization of neurons and synapses in driving secondary injury and cognitive decline in both acute and chronic phases after TBI [15], the role of complement receptors has not been specifically investigated in TBI. The gene discussed is C3; the disease is Mental deterioration.